My last post of the night (you're welcome). I begged

New Post Public Reply Private Reply Replies (1) Message Board
RTB
686
My last post of the night (you're welcome). I begged Respert to post, but I haven't heard from him yet. So, you are going to get a mix of daytime RTB and nighttime RTB.

Today was a tough day. We all lost 3, 4, 5, 6 or maybe even 7 figures today. Pretty much sucks. I told my wife that I "won" the IH trial trial guessing contest. She said, "what did you win?" I said, we lost $90,000. She said, "don't enter any more contests."

It isn't just the money, it is the further delays. Like you, I think that LL can help and should get EUA. But, I don't see that happening for at least 5 months (O, Canada!!!, can you help??? O, Philippines, how 'bout you??)

This is the point of my post......I would love to see this group pull a bit back towards the middle and be realistic. If we put our predictions on a bell curve (see post 79624), the actual result would have likely been "off the chart" or in the farthest small tail. We, as a group, were so far off, it is embarrassing.

We are supposed to know something about Leronlimab, and, in fact, this group knows more than just about anyone. But we have to have some realistic evaluation and perspective. It isn't helpful if we all just blow smoke at each other (rainbows and unicorns).

Why is it important to be a realist and to speak the truth to each other and to other investors? So we can hold management accountable.

The next time we are asked to vote on BOD members, or management compensation or options, let's hold people accountable. We (as a group) screwed up in a big way last September when we approved the executive options.

This executive team has had to return excessive grants (TWICE). That is amazing. The board, including the CEO and the Chairman (not to mention the CFO) have cashed out a large portion of their holdings. Wake up! We can root for success, but don't vote them more shares/options.

Last point......sometime in the next five months.....you might be asked to vote on a buy-out. Vote with your head, not your hopes. (You, we, and me have already proven that we don't really have any flipping idea how a trial is going to turn out.) If you love the drug, then invest in the buyer.

I'm a little embarrassed to be preaching and don't really have any right. But, come on folks, just be realistic about what has happened here.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

FullStack Modular Launches New Facility to Transform Housing

Updated Category News Views 459

Revolutionizing Construction with a New Facility FullStack Modular, an American leader in modular construction, has officially opened its new manufacturing facility on the West Coast. This marks a significant expansion for the company, which aims to address critical housing shortages with innovative construction solutions. The new site promises to enhance the speed and...

Continue Reading
Toyota Motor Credit Enhances Financing with New EMTN Program

Updated Category News Views 128

Toyota Motor Credit Corporation Renews EMTN Program Toyota Motor Credit Corporation (TMCC) has successfully renewed its Euro Medium Term Note Programme (EMTN Program), which allows for the potential issuance of unsecured notes totaling up to €60 billion. This renewal, effective as of late, enables TMCC and its affiliates to issue notes according to specific conditions...

Continue Reading
Discover the Essence of Summer with Pure Michigan's FRESH Fragrance

Updated Category News Views 273

Pure Michigan Unveils Exciting New Fragrance FRESH Pure Michigan has recently launched an invigorating summer fragrance named FRESH, encapsulating the picturesque beauty of Michigan's coastline, wineries, lavender fields, and the light-hearted spirit of summer. Each element of this new fragrance aims to bring the essence of vacationing in Michigan to consumers. Aromas...

Continue Reading
CATL Introduces TENER Flex: The Future of Energy Storage

Updated Category News Views 181

When it comes to renewable energy, innovation is the name of the game. CATL has just kicked things up a notch with its unveiling of the TENER Flex Energy Storage System at the Solar & Storage Live (SSL) 2024 event. This isn’t just another gadget; it’s a leap towards creating efficient and sustainable energy solutions that cater to an ever-growing market hungry for...

Continue Reading
BioCryst Pharmaceuticals Plans Fourth Quarter Financial Call

Updated Category News Views 94

BioCryst Pharmaceuticals to Discuss Upcoming Financial Results BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) has announced its schedule to report financial results for the fourth quarter of 2024. This important update is set for a Monday in late February. Insights from the Conference Call The company’s management will host a conference call on the same day at 8:30 a.m....

Continue Reading